Browsing: Disease Area > Rare tumors
In this report the authors discuss diagnosis and treatment of a patient with leiomyosarcoma of the stomach, whose disease progressed 2 years after he was disease-free following initial treatment.
Scientists have revealed that a human protein – identified as YTHDF2 – could prevent cancer by restricting the human herpes virus 8, otherwise known as Kaposi’s sarcoma-associated herpesvirus.
Patients with cancerous forms of gestational trophoblastic disease went into remission after treatment with pembrolizumab.
A team of scientists have bound gene editing CRISPR/Cas9 to nucleotide aptamers to selectively target and edit osteosarcoma cancer cells.
The largest genomics study of chordoma to date has discovered a gene mutation possessed by some patients which is a target for existing drugs known as PI3K inhibitors. Previously, these drugs have not been considered for chordoma.
Proper staging, early detection and accurate diagnosis all play a key role in successful treatment for cancer patients. Discover some of the treatment options for mesothelioma in this opinion piece.
Patients with rare cancers who are not able to receive standard treatment may be able to receive existing therapies designed for different cancers with the same genetic mutations, according to a novel study.
In this interview you can discover the current treatment options for mesothelioma as well as advancements that have been made in immunotherapy for this disease and what is being done to advance patient selection for this treatment modality.
In this article, the authors provide an up-to-date review of all reported genomic aberrations in the eight most common pediatric solid tumors with whole-exome sequencing or whole-genome sequencing data.